XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Cash, Cash Equivalents and Investments
3 Months Ended
Mar. 31, 2023
Fair Value Disclosures [Abstract]  
Cash, Cash Equivalents and Investments

Note 4. Cash, Cash Equivalents and Investments

 

The following tables categorize the fair values of cash, cash equivalents, short-term investments and long-term investments measured at fair value on a recurring basis on our balance sheets (in thousands):

 

 

 

March 31, 2023

 

 

December 31, 2022

 

Cash and cash equivalents:

 

 

 

 

 

 

Cash

 

$

4,449

 

 

$

3,986

 

Money market funds

 

 

15,863

 

 

 

10,988

 

Repurchase agreements

 

 

 

 

 

9,000

 

Government and agency notes

 

 

26,402

 

 

 

20,605

 

Total cash and cash equivalents

 

$

46,714

 

 

$

44,579

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

Certificates of deposit

 

$

5,166

 

 

$

5,390

 

Municipal notes

 

 

400

 

 

 

506

 

Corporate notes

 

 

7,799

 

 

 

12,411

 

Government and agency notes

 

 

30,124

 

 

 

27,295

 

Total short-term investments

 

$

43,489

 

 

$

45,602

 

 

 

 

 

 

 

Long-term investments

 

 

 

 

 

 

Certificates of deposit

 

$

475

 

 

 

712

 

Government and agency notes

 

 

 

 

 

2,866

 

Total long-term investments

 

$

475

 

 

$

3,578

 

Equity investments without readily determinable fair values assessed under the measurement alternative

Equity investments without readily determinable fair value include ownership rights that either (i) do not meet the definition of in-substance common stock or (ii) do not provide the Company with control or significant influence and these investments do not have readily determinable fair values.

During the three months ended March 31, 2023, the Company received approximately $70,000 in equity investments without readily determinable fair values of Lighthouse, Inc. in exchange for the Legacy Assets. As of March 31, 2023, the Company has not recorded any cumulative upward adjustments or cumulative impairments for its equity investments without readily determinable fair values.